These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
475 related articles for article (PubMed ID: 18772098)
1. Complications after second trimester surgical and medical abortion. Grossman D; Blanchard K; Blumenthal P Reprod Health Matters; 2008 May; 16(31 Suppl):173-82. PubMed ID: 18772098 [TBL] [Abstract][Full Text] [Related]
2. Second trimester medical abortion with mifepristone-misoprostol and misoprostol alone: a review of methods and management. Gemzell-Danielsson K; Lalitkumar S Reprod Health Matters; 2008 May; 16(31 Suppl):162-72. PubMed ID: 18772097 [TBL] [Abstract][Full Text] [Related]
3. A randomised controlled trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion up to 13 weeks of gestation. Hamoda H; Ashok PW; Flett GM; Templeton A BJOG; 2005 Aug; 112(8):1102-8. PubMed ID: 16045525 [TBL] [Abstract][Full Text] [Related]
4. Randomised controlled trial comparing the efficacy of same-day administration of mifepristone and misoprostol for termination of pregnancy with the standard 36 to 48 hour protocol. Guest J; Chien PF; Thomson MA; Kosseim ML BJOG; 2007 Feb; 114(2):207-15. PubMed ID: 17305893 [TBL] [Abstract][Full Text] [Related]
5. A randomized trial to compare two dosing intervals of misoprostol following mifepristone administration in second trimester medical abortion. Chai J; Tang OS; Hong QQ; Chen QF; Cheng LN; Ng E; Ho PC Hum Reprod; 2009 Feb; 24(2):320-4. PubMed ID: 19049993 [TBL] [Abstract][Full Text] [Related]
6. Regimens of misoprostol with mifepristone for early medical abortion: a randomised trial. Shannon C; Wiebe E; Jacot F; Guilbert E; Dunn S; Sheldon WR; Winikoff B BJOG; 2006 Jun; 113(6):621-8. PubMed ID: 16709204 [TBL] [Abstract][Full Text] [Related]
7. [The efficacy and acceptability of mifepristone medical abortion with home administration misoprostol provided by private providers linked with the hospital: a prospective study of 433 patients]. Faucher P; Baunot N; Madelenat P Gynecol Obstet Fertil; 2005 Apr; 33(4):220-7. PubMed ID: 15894206 [TBL] [Abstract][Full Text] [Related]
11. Mifepristone- and misoprostol-induced mid-trimester termination of pregnancy: a review of 272 cases. Rose SB; Shand C; Simmons A Aust N Z J Obstet Gynaecol; 2006 Dec; 46(6):479-85. PubMed ID: 17116051 [TBL] [Abstract][Full Text] [Related]
12. Increasing women's choices in medical abortion: a study of misoprostol 400 microg swallowed immediately or held sublingually following 200 mg mifepristone. Akin A; Dabash R; Dilbaz B; Aktün H; Dursun P; Kiran S; Aksan G; Doğan B; Winikoff B Eur J Contracept Reprod Health Care; 2009 Jun; 14(3):169-75. PubMed ID: 19565414 [TBL] [Abstract][Full Text] [Related]
13. Induction of second trimester abortion (12-20 weeks) with mifepristone and misoprostol: a review of 386 consecutive cases. Goh SE; Thong KJ Contraception; 2006 May; 73(5):516-9. PubMed ID: 16627037 [TBL] [Abstract][Full Text] [Related]
14. Is induced abortion with misoprostol a risk factor for late abortion or preterm delivery in subsequent pregnancies? Winer N; Resche-Rigon M; Morin C; Ville Y; Rozenberg P Eur J Obstet Gynecol Reprod Biol; 2009 Jul; 145(1):53-6. PubMed ID: 19427095 [TBL] [Abstract][Full Text] [Related]
15. Vaginal vs. sublingual misoprostol with mifepristone for cervical priming in second-trimester abortion by dilation and evacuation: a randomized clinical trial. Carbonell JL; Gallego FG; Llorente MP; Bermudez SB; Sala ES; González LV; Texido CS Contraception; 2007 Mar; 75(3):230-7. PubMed ID: 17303495 [TBL] [Abstract][Full Text] [Related]
16. Serious adverse events associated with the use of misoprostol alone for cervical preparation prior to early second trimester abortions (12-16 weeks). Nucatola D; Saulsberry V; Gatter M; Roth N Contraception; 2009 Feb; 79(2):158. PubMed ID: 19135576 [No Abstract] [Full Text] [Related]
17. Acceptability of suction curettage and mifepristone abortion in the United States: a prospective comparison study. Jensen JT; Harvey SM; Beckman LJ Am J Obstet Gynecol; 2000 Jun; 182(6):1292-9. PubMed ID: 10871441 [TBL] [Abstract][Full Text] [Related]
18. Surgical versus medical methods for second trimester induced abortion. Lohr PA; Hayes JL; Gemzell-Danielsson K Cochrane Database Syst Rev; 2008 Jan; (1):CD006714. PubMed ID: 18254113 [TBL] [Abstract][Full Text] [Related]
19. Outcomes for subsequent pregnancy in women who have undergone misoprostol mid-trimester termination of pregnancy. Mirmilstein V; Rowlands S; King JF Aust N Z J Obstet Gynaecol; 2009 Apr; 49(2):195-7. PubMed ID: 19432610 [TBL] [Abstract][Full Text] [Related]
20. Comparison of complications associated with induction by misoprostol versus dilation and evacuation for second-trimester abortion. Sonalkar S; Ogden SN; Tran LK; Chen AY Int J Gynaecol Obstet; 2017 Sep; 138(3):272-275. PubMed ID: 28585710 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]